This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders. Its structure, featuring a piperidine ring and isoindoline-1,3-dione moiety, makes it a valuable intermediate in designing molecules that interact with central nervous system receptors. It is often explored for its potential in creating drugs for conditions such as anxiety, depression, and cognitive impairments. Additionally, its chiral nature allows for the development of enantiomerically pure compounds, enhancing specificity and reducing side effects in therapeutic applications. Researchers also investigate its use in the development of enzyme inhibitors and modulators of biological pathways relevant to neurodegenerative diseases.